PI
ELV icon

PEAK6 Investments’s Elevance Health ELV Stock Holding History

PEAK6 Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.49M Sell
14,400
-5,100
-26% -$2.72M 0.02% 719
2024
Q2 		$10.6M Buy
19,500
+17,300
+786% +$9.14M 0.03% 464
2024
Q1 		$1.14M Buy
2,200
+1,600
+267% +$796K ﹤0.01% 1831
2023
Q4 		$283K Hold
600
– – ﹤0.01% 3009
2023
Q3 		$261K Sell
600
-1,100
-65% -$499K ﹤0.01% 2883
2023
Q2 		$755K Sell
1,700
-6,500
-79% -$3M ﹤0.01% 1906
2023
Q1 		$3.77M Buy
8,200
+300
+4% +$143K 0.02% 865
2022
Q4 		$4.05M Buy
7,900
+5,700
+259% +$2.89M 0.02% 838
2022
Q3 		$999K Sell
2,200
-4,200
-66% -$2.01M ﹤0.01% 2208
2022
Q2 		$3.02M Sell
6,400
-600
-9% -$297K 0.01% 1862
2022
Q1 		$3.44M Sell
7,000
-9,202
-57% -$4.21M 0.01% 1380
2021
Q4 		$7.51M Sell
16,202
-9,398
-37% -$3.95M 0.02% 886
2021
Q3 		$9.54M Buy
25,600
+2,028
+9% +$771K 0.02% 730
2021
Q2 		$11.7M Buy
23,572
+15,072
+177% +$5.76M 0.03% 606
2021
Q1 		$3.05M Sell
8,500
-32,700
-79% -$10.5M 0.01% 1478
2020
Q4 		$13.2M Buy
41,200
+8,400
+26% +$2.58M 0.03% 546
2020
Q3 		$8.81M Buy
32,800
+11,600
+55% +$3.12M 0.02% 646
2020
Q2 		$5.58M Buy
21,200
+18,200
+607% +$4.86M 0.02% 749
2020
Q1 		$681K Sell
3,000
-60,700
-95% -$16.5M ﹤0.01% 1822
2019
Q4 		$19.2M Buy
63,700
+54,100
+564% +$14.9M 0.1% 194
2019
Q3 		$2.31M Buy
9,600
+4,600
+92% +$1.26M 0.01% 1187
2019
Q2 		$1.41M Sell
5,000
-3,700
-43% -$1.01M 0.01% 1544
2019
Q1 		$2.5M Sell
8,700
-2,700
-24% -$781K 0.01% 1146
2018
Q4 		$2.99M Sell
11,400
-4,900
-30% -$1.35M 0.02% 948
2018
Q3 		$4.47M Buy
+16,300
New +$4.23M 0.02% 864

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PEAK6 Investments's ELV Position: Q3 2024 in Review

PEAK6 Investments sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 2 shares — an estimated $1.07K sold.

PEAK6 Investments first reported a position in ELV in Q1 2019 and held it in 20 quarters. The position peaked at $17.4M in Q2 2019. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • PEAK6 Investments reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • PEAK6 Investments sold 2 Elevance Health shares in Q3 2024, an estimated $1.07K.
  • PEAK6 Investments first reported a position in Elevance Health in Q1 2019 and held it in 20 quarters.
  • PEAK6 Investments's Elevance Health position peaked at $17.4M in Q2 2019.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.